Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause characterized by expansion of autoreactive lymphocytes. Regulatory T cells (T regs ) are a component of the normal immune system and contribute to the maintenance of peripheral tolerance. T reg abnormalities have been associated with several autoimmune diseases and there is interest in the role of T regs in SLE. We previously demonstrated that transfer of expanded CD4
HI T regs slows the development of lupus in (NZBxNZW)F 1 (B/W) mice. However in the absence of T reg specific surface antigens, cell purification remains a compromise between the breadth and purity of the population isolated. Importantly, purified populations always contain Foxp3 2 effector T cells (T effs ) that theoretically could exacerbate autoimmunity in the recipient. Here we explore the impact of transferring the more comprehensive, but less pure T reg subset defined by CD4 + CD25 + expression on development of murine lupus. All cells were FACS sorted and expanded prior to adoptive transfer. Development of proteinuria and survival were measured. We found that exogenous expansion of CD4 + CD25 + cells produced a population containing 70-85% CD4 + Foxp3 + T regs . Expanded T regs had higher CTLA-4 and Foxp3 expression, increased in vitro suppression capacity, and prolonged in vivo survival as compared to freshly isolated cells. Adoptive transfer of expanded CD4 + CD25 + T regs inhibited the onset of glomerulonephritis and prolonged survival in mice. Importantly the population of T eff contained within the adoptively transferred cells had reduced survival and proliferation capacity as compared to either co-transferred T regs or transferred T effs expanded in the absence of T regs . These studies demonstrate that adoptive transfer of expanded CD4 + CD25
+

Foxp3
+ T regs has the capacity to inhibit the onset of murine lupus and that this capacity is significant despite transfer of co-cultured T eff cells. These data indicate that when coexpanded with regulatory T cells, exogenously activated T effs from autoimmune patients may not pose a significant risk of promoting disease.
Introduction
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by loss of tolerance to self-antigens, expansion of autoreactive lymphocytes, and immune mediated injury to multiple organ systems. The immunologic defects that permit development of SLE are incompletely understood, but as with other autoimmune diseases there is a failure to inhibit activation and expansion of autoreactive lymphocytes that escape central tolerance mechanisms. Natural regulatory T cells (T regs ) are a thymically derived subset of CD4 + lymphocytes present in both humans and mice that serve an essential role in modulating the function of the immune system and in maintaining peripheral tolerance [1] [2] [3] [4] . In vitro, CD4
+ T regs have a strong capacity to inhibit activation and expansion of both alloreactive and autoreactive T cells [3, 5] . In vivo, the T reg T cell receptor (TCR) repertoire is biased towards recognition of self-antigens [6, 7] and upon activation, T regs exert a potent capacity to inhibit autoreactive lymphocytes [6] [7] [8] [9] [10] [11] . Recognition of the important role of T regs in maintenance of peripheral tolerance has led to studies demonstrating an association between abnormal T reg function or prevalence and the development of autoimmune disease [8, 10, 12, 13] . In several mouse systems, studies have demonstrated that therapies that restore or supplement T reg function and numbers can inhibit the onset and progression of some autoimmune diseases [8, [12] [13] [14] [15] [16] .
A number of studies have examined the relation between T regs and SLE. In some but not all mouse models of lupus, defects in T reg prevalence or function have been reported [13, 17, 18] . Similarly, a growing number of reports have described defects in the number and function of T regs isolated from peripheral blood of patients with active SLE [19] [20] [21] [22] [23] . These observations suggest that T reg dysfunction may be a contributing factor in the immune pathogenesis of SLE. We have previously demonstrated that supplementation of endogenous T regs utilizing a highly purified, exogenously activated and expanded T reg subset characterized by CD4 + CD25 + CD62L HI expression can inhibit the onset and rate of progression of lupus in (NZBxNZW)F 1 (B/W) mice [24] . This study suggested the possibility that augmentation of the regulatory T cell population and/or function in vivo might be beneficial. However, although these cells were able to inhibit disease, the population transferred reflected only a subset of natural T regs in mice with active lupus. Some evidence suggests that different T reg subsets may have unique roles in the maintenance of peripheral tolerance and thus transfer of a more comprehensive T reg subset may have additional or unique therapeutic benefits [10, [25] [26] [27] . In addition, the intrinsic resistance of T regs to exogenous expansion and the probability that a large number of T regs will be required to enhance peripheral tolerance in humans makes it desirable to isolate a larger T regs subset for exogenous expansion. Unfortunately, due to the lack of T reg specific surface antigens, purification of a more comprehensive T reg subset increases the contamination by the non-regulatory effector T cell (T eff ) population. Despite a growing number of published purification protocols for isolating subsets of regulatory T cells, no approach to date has demonstrated the capacity to isolate the entire T reg population with 100 percent specificity. Recent studies demonstrate that even the intracellular transcription factor Foxp3, considered the gold standard for identification of regulatory cells, is expressed transiently in some activated non-regulatory human T cells [28] further highlighting the difficulty in both identifying and purifying a comprehensive regulatory T cell population. Importantly, in autoimmune prone mice or humans with SLE, contamination of therapeutic T regs by non-regulatory effector cells can include pathologic autoreactive lymphocytes that may have potential to exacerbate autoimmune disease if expanded and transferred back into the donor.
In this study we isolate and expand CD4 
Materials and Methods
Mice
Six-week-old B/W mice were purchased from Jackson Laboratories (Bar Harbor, Maine) and housed in the AAALAC accredited San Francisco VAMC Animal Care Facility under the supervision of a licensed veterinarian. The VAMC Institutional Animal Care Use Committee reviewed and approved all protocols utilized in this study.
Antibodies and reagents
Monoclonal antibody (mAb) against CD4 (GK1.5), anti-Fc (2.4G2) and anti-CD3 (2C11), were purified in our lab. The GK1.5 mAb was FITC-conjugated. CD4 mAb (PerCp-Cy5.5 conjugated, RM4-5), CD62L (allophycocyanin(APC)-conjugated, MEL-14), and neutralizing antibodies to IL-10 (JES5-16E3) were purchased from BD Pharmingen (San Diego, CA). Pacific Blue-CD4 (RM4-5), Foxp3 mAb (FITC-conjugated and APC-conjugated, FJK-16s), isotype control (rat IgG2a), fixation and permeabilization buffers (catalog no. 00-5523) were purchased from eBioscience (San Diego, CA). Biotinylated goat anti-mouse IgG (catalog no. M30215), goat anti-mouse IgM (catalog no. M31515), and FITC-conjugated streptavidin (SA1001) were purchased from Caltag Laboratories (Burlingame, CA). Biotinylated rat anti-mouse C3 (11H9) was purchased from HyCult Biotechnology (The Netherlands). The anti-CD25 mAb (R-PEconjugated, 7D4) and anti-CTLA4 mAb (R-PE-conjugated, 1B8) were purchased from Southern Biotechnology Associates, Inc (Birmingham, AL). Neutralizing antibodies to TGF-b (1D11) were purchased from R&D Systems (Minneapolis, MN). Carboxyfluoroscein succinimidyl ester (CFSE) and SNARF-1 carboxylic acid, acetate, succinimidyl ester (S22801, special packaging) was purchased from Molecular Probes/Invitrogen Life Technologies (Carlsbad, CA).
Lymphocyte isolation
Following animal sacrifice, the spleen and cervical, axillary, inguinal, and renal lymph nodes were harvested. Single cell suspensions were prepared in DMEM with 2% fetal calf serum (FCS) by passing tissue through nylon mesh. In experiments of CFSE or SNARF-1 labeled in vivo cell survival, salivary glands, kidneys, lung and liver were also mechanically dissociated and lymphocytes from these tissues were isolated by ficoll gradient.
FACS analysis and cell sorting
Cell suspensions were blocked with anti-Fc mAb prior to monoclonal antibody labeling. Lymphocytes were labeled with PerCp-Cy5.5-CD4 or FITC-CD4, PE-CD25, APC-CD62L. Foxp3 expression was measured utilizing an aliquot of cells stained with PerCp-Cy5.5-CD4 that was fixed and permeabilized, blocked with anti-Fc mAb, and stained with FITC-Foxp3 or FITC-IgG2a isotype control per manufacturers instructions (eBioscience, San Diego, CA). Combined expression of membrane bound and intracellular CTLA-4 expression was measured by first labeling surface antigen and then utilizing the fixation and permeabilization and blocking protocol defined for Foxp3 above to label intracellular antigen. All FACS analysis and sorting was performed on a FACSAria (Becton Dickinson, Mountain View, CA) instrument utilizing FACSDiva software and the purity prioritization algorithm. Purity checks of sorted cells routinely demonstrated greater than 98% purity. 
Cell culture
Suppression assay
The CD4 + CD25 2 CD62L HI T cells were purified by FACS and served as responder T cells (T resp ) in mixed lymphocyte suppression assays. CD4
+ depleted splenocytes were irradiated at 2,000 rads and served as antigen presenting cells (APCs). Purified T resp and APCs (75,000 each) were combined in 96 well U-bottom plates with soluble anti-CD3 at 4 mg/ml. T regs were added to obtain a range of T resp :T reg ratios. Cells were cultured for 60 hours prior to addition of 1 mCi/well of [ 3 H] thymidine and the assay was then harvested 12 hours later. All assays were performed in triplicate. Tritium incorporation was measured on a MicroBeta Scintillation Counter (Wallac Oy, Turku Finland). The tritium incorporation at each T resp :T reg was divided by incorporation in the T resp only wells to calculate a suppression index (SI) for each experiment.
In vivo survival of adoptively transferred T regs and T effs
The in vivo survival of both freshly isolated and exogenously expanded T regs and expanded T effs was assessed in a series of experiments utilizing adoptively transferred CFSE or SNARF-1 labeled cells. All adoptive transfer studies reported in this paper utilized unmanipulated recipient mice (no irradiation or immune depletion prior to adoptive transfer). Lymphocytes from donor mice were FACS sorted and the frequency of T regs and T effs in freshly sorted populations was measured by FACS analysis of Foxp3 expression in an aliquot of sorted cells. Expanded cells obtained from the 8-day expansion protocol described above were also analyzed for Foxp3 expression to determine the ratio of T regs to non-regulatory T eff post-expansion. Fresh or expanded cells were CFSE labeled, extensively washed in sterile saline, and concentrated in 200 ml of sterile PBS in preparation for tail-vein injection to each mouse. The survival of both freshly isolated and exogenously expanded cells was measured at set time intervals from 2 to 30 days following adoptive transfer. Mice were sacrificed and single cell suspensions of lymph node and spleen were prepared. In order to detect CFSE + cells that trafficked outside of the lymphatic system, lymphocytes were also recovered from salivary glands, kidneys, lung and liver. Recovered cells were stained with Pacific Blue-CD4 and APC-Foxp3 mAbs prior to FACS analysis in order to differentiate the survival and proliferation of CFSE
2 T effs . In these experiments, two types of CD4 + Foxp3 2 T effs were designated based on the culture conditions from which they were derived. The first T eff population was derived from the CD4 + CD25 + Foxp3 2 T effs (5-10% of cells) co-isolated during sorting for CD4 +
CD25
+ Foxp3 + T regs . During cell culture, these contaminating T effs are co-expanded in a T reg predominant environment and were therefore designated as ''conditioned T effs '' (T eff-conditioned ) to reflect potential conditioning of the T eff function by T reg co-culture. A second population of T eff cells was generated by first depleting the CD4 + CD25 + T cells (the majority of T regs )
prior to the in vitro expansion of for 8-days. This expanded T eff population contained ,2% CD4 + Foxp3 + T reg cells and was therefore considered as ''unconditioned'' T effs . In specified experiments designed to assess differential survival of ''unconditioned'' T eff cells from T eff-conditioned cells following co-injection with T regs , mice received two tail-vein injections on the same day, one containing expanded, SNARF-1 labeled unconditioned T effs and the second injection containing the expanded CFSE labeled T regs /T eff-conditioned cells. Mice were sacrificed 4 or 5 days after injection and cell survival was assessed by FACS analysis of lymphocytes recovered from lymphatic and solid organ tissue of recipient mice (as defined above 
Assessment of lupus disease activity and survival
A total of 65 mice (21-22 mice per group) were followed for the development of renal disease as measured by proteinuria and for survival. Proteinuria was measured using Uristix (Bayer Corp, Elkhart, IN). Antibodies to double-stranded DNA (anti-dsDNA Ab) were measured utilizing an ELISA previously established in our lab [30] . In a separate experiment, cohorts of 29-week old mice (5 per arm) received either T regs or PBS control (as per the above protocol) and these mice were then sacrificed 8-weeks following adoptive transfer to provide renal histology. Fixed kidney tissue was stained with hematoxylin and eosin for evaluation of glomerulosclerosis and tubular damage and cryopreserved sections of kidney tissue were stained with FITC conjugated antibodies to IgG, IgM, and C3 for assessment of immune complex deposition that was scored by a blinded reader using a scoring system previously established in our laboratory [30] .
Statistical analysis
Suppression assays were performed in triplicate and the mean thymidine incorporation was assessed using the Mann-Whitney U test. Antigen expression by mean fluorescent intensity, antidsDNA Ab titers and renal histologic damage and immune complex deposition scores were compared by Mann-Whitney U test. Development of proteinuria, defined as $100 mg/dl on serial testing, and survival in treatment and control cohorts were compared by x 2 analysis using the Yates correction. + purity (65-85%) due to the higher initial T eff prevalence ( Figure 1C ). On average, culture of the entire CD4 +
Results
Purification and expansion of CD4
CD25
+ cell population produced a population that expanded 30 to 40-fold and was 70-85% CD4 + Foxp3 + ( Figure 1D ).
In vitro T reg suppressor function is similar between subsets of CD25 + T regs and this function is enhanced by in vitro activation and expansion
We previously demonstrated that the in vitro suppressive capacity of the CD4 +
CD25
+ CD62L HI T reg fraction is not affected by the age or disease state of donor B/W mice and is equivalent to that of similar cells from non-autoimmune prone BALB/c mice [24] . In this study, the CD4 (Figure 2A , p$0.25 for each cell ratio, 3-6 mice per group).
To evaluate the effect of ex vivo expansion on suppressive function, we isolated the entire CD4 +
+ T cell population and measured in vitro suppressive function before and after expansion. Despite the presence of 15-20% co-expanded T effs , the expanded CD4
+ T regs demonstrated significantly enhanced suppression capacity across the range of T resp :T reg ratios tested as compared to freshly isolated CD4 +
+ cells ( Figure 2B, p#0 .04 for each cell ratio, 6 mice per group). This enhanced T reg suppressor function following exogenous expansion is consistent with prior reports of T reg function in other murine models and with our previous findings with the CD4 + CD25 + CD62L HI T reg fraction in B/W mice [24, 31] . Because levels of Foxp3 + and CTLA-4 expression in T regs have been correlated with suppressor function of these cells and these antigens are also known to be up-regulated by T reg activation, we measured their expression in freshly isolated and exogenously expanded T regs from young and old B/W mice by FACS. Levels of Foxp3 or CTLA-4 expression in freshly isolated T regs as measured by mean fluorescent intensity (MFI) did not vary with mouse age or organ distribution (data not shown). However, consistent with prior reports in other mouse strains [29, 31] there was a marked increase in both Foxp3
+ and CTLA-4 expression in B/W T regs following exogenous expansion ( Figure 2C -D, p,0.01 for both, 3-6 mice per group).
Exogenous expansion significantly enhances in vivo survival of T regs , but not of co-cultured T eff
We assessed the in vivo survival of freshly isolated and exogenously expanded T regs and expanded T eff cells in a series of transfer experiments utilizing mixed populations of expanded T regs /T eff-conditioned , and T effs . Prior studies have shown that T reg interactions with T effs can induce long term T eff anergy [32, 33] 
Foxp3
+ cells (as a percentage of all cells in the aliquot) and the total cell recovery from each mouse was then used to estimate the T reg survival in each mouse. As shown in Figure 3 , in vivo survival of exogenously expanded, adoptively transferred T regs at day 5 is significantly enhanced as compared to that of freshly isolated cells (p,0.01). Freshly isolated, adoptively transferred CFSE + T regs could no longer be consistently detected by FACS when mice were examined 10 days post transfer.
The long-term in vivo survival of exogenously expanded T regs was then assessed by following 10610 6 cells for up to 30 days following transfer (3 mouse cohort). As shown in Figure 4 , a small population of CFSE + positive cells could be detected at 30 days ( Figure 4A , ,0.2% of CD4 + T cells). To ensure these rare cells were actually the adoptively transferred CFSE labeled T regs and not just very large cells or cellular doublets with bright autofluorescence, the CFSE bright population was FACS sorted and stained for Foxp3 expression. As shown in Figure 4B , Foxp3 was detected in .90% of CFSE + cells consistent with long term survival and proliferation of exogenously expanded, adoptively transferred T reg .
To assess the survival of contaminating, co-transferred T eff cells contained within the expanded T reg population, cohorts of 3 mice received expanded CD4 +
CD25
+ cells derived from the high purity T reg culture that contained 85% CD4 + Foxp3 + T regs and 15% contaminating CD4 + Foxp3 2 T eff-conditioned ( Figure 5A ). Two to eight days following transfer mice were sacrificed and the lymph node, spleen, and tissue infiltrating lymphocytes were FACS analyzed for CFSE and Foxp3. As demonstrated in Figure 5B -C, the frequency of CFSE + Foxp3 2 T eff-conditioned relative to CFSE + -Foxp3 + T regs rapidly declined such that by day 4 the T eff-conditioned comprised ,3% of the transferred cells (an 80% decline) with no evidence of significant T eff-conditioned division by CFSE dilution. To determine if this decline in T effs prevalence was a result of conditioning during co-culture with T regs or an intrinsic property of all exogenously expanded, adoptively transferred T effs , in vivo survival of T effs expanded in the absence of T regs was assessed (''unconditioned'' T effs generated from expansion of CD25-depleted CD4 + T cells. Expanded cells were 98% CD4 + Foxp3 2 -T effs ). In the first experiment, survival and division of 5610 6 transferred CFSE labeled, Foxp3 2 unconditioned T effs could be detected by FACS up to seventeen days post-transfer, at which time CFSE fluorescent intensity approached the autofluorescence baseline ( Figure 6 ). The relative survival of unconditioned T effs was then compared to survival of expanded T regs following transfer of these two populations into the same mouse. Mice received injections of 3.45610 6 Figure 7A -B show a characteristic result at day 4 at which time approximately equal numbers of CSFE and SNARF-1 labeled cells could be recovered from the lymphatic system and organs (0.4% of total lymphocytes each, ratio of sorted CFSE to SNARF-1 is 54% to 46%). Foxp3 analysis of recovered CFSE + cells demonstrates that these cells are comprised almost entirely of T regs ( Figure 7C , 97% of surviving CFSE + cells are Foxp3 + T regs , 3% Foxp3 2 T eff-conditioned ). Recovered SNARF-1 + were unconditioned T effs as expected ( Figure 7D , 99% Foxp3
2 ) (characteristic findings from 5 mice). This data is consistent with evidence in Figures 5 and 6 demonstrating that impaired T eff-conditioned survival is a consequence of co-culture with T regs and not an intrinsic characteristic of all adoptively transferred T effs .
Adoptive transfer of exogenously expanded CD4
+ CD25
+ T regs to pre-nephritis mice slows the progression to proteinuria and prolongs survival
To determine if adoptive transfer of a mixed population of exogenously expanded CD4 + CD25 + T regs can suppress murine lupus, we transferred cells to a large cohort of 29 week-old B/W mice without clinical disease. Treatment mice received 6610 6 T regs via tail vein injection, based on our prior ability to delay disease onset utilizing this number of CD62L HI T regs . Control mice received either an equivalent number of exogenous expanded CD4 + CD25 2 cells or PBS. Following adoptive transfer, mice in the active treatment group had delayed progression to significant renal disease, such that eight weeks after cell transfer, only 32% of animals in the treatment group had developed proteinuria compared to 59% in the CD4 +
CD25
2 T eff mice and 62% in the PBS control group (Figure 8 , p,0.025 for both comparisons. Dataset S1 contains proteinuria and survival data). Mice sacrificed for renal pathology and immunohistochemical evaluation at 8 weeks following the initiation of therapy exhibited diminished immune complex deposition among those that received T regs (Dataset S2 contains proteinuria data). Indirect immunfluorescence demonstrated that kidneys from T reg treated mice (Figure 9 , A-B) had less IgG and IgM immune complex deposition as compared to control treated mice (Figure 9 , C-D, p#0.05 for both comparisons. Differences in C3 deposition and renal damage pathologic scoring did not reach statistical significance). The prevalence of proteinuria in T reg treated mice remained significantly lower than either control group up to 12 weeks following the adoptive transfer (p#0.008 for both comparisons). Inhibition of renal disease in T reg recipients correlated with an improved survival first evident 9 weeks following adoptive transfer (Figure 10) , p,0.05 T reg vs. either control. This survival advantage in the T reg recipients remained significant during the 12 weeks following transfer (p#0.026). In mice followed beyond the 12-week experiment (15 Tr eg , 15 T eff , 14 PBS), it was observed that the majority of mice in each treatment arm eventually developed proteinuria, but the delay in disease onset and prolonged survival of T reg recipient mice remained evident to 24 weeks following therapy (Dataset S1). At baseline, all mice in each treatment arm had anti-dsDNA antibody titers below the detection threshold. Significant variability in autoantibody titer was observed among mice in each group during follow-up and the difference between groups did not reach statistical significance.
Discussion
In this report we expand on our prior work demonstrating the ability of exogenously expanded, adoptively transferred T regs to inhibit the development of murine lupus. We demonstrate that exogenous expansion and transfer of T regs contained within the population of CD4 +
CD25
+ T cells suppresses the onset of glomerulonephritis and prolongs survival in a murine model of lupus. Importantly, the co-transfer of a population of co-purified/ co-expanded T effs did not negate this therapeutic benefit in mice. These results underscore the remarkable ability of T regs to suppress autoreactive immune responses. They also address an important concern with respect to the therapeutic potential of this approach in terms of the risk of simultaneous transfer of activated, autoreactive and pathogenic T effs to autoimmune recipients. In this study we found that co-expanded and transferred T eff , that are present as a consequence of sorting and expanding T regs without the availability of T reg specific cell surface antigens, did not off-set the therapeutic benefit of exogenously expanded, adoptively transferred T regs . In addition, we tracked the survival and proliferation of non-regulatory/Foxp3 2 cells co-transferred with the T reg population and found T effs expanded in the presence of T regs do not persist in vivo, particularly compared to transferred Foxp3 + T regs . The poor survival and lack of division of the cocultured Foxp3 2 T effs produced under our in vitro expansion conditions indicates these cells are unlikely to have the capacity to contribute either to the disease suppression (as iT regs ) or adversely to the pool of self-reactive T effs . This observation is consistent with the evidence that activated T regs produce a significant amount of TGF-b and that both human and mouse T effs activated in the presence of TGF-b develop an anergic phenotype and under some conditions can be converted to an induced suppressor cell (iT reg ) [32, 34, 35] . This finding is an important first step in considering the possibility of utilizing T reg as a therapeutic approach in humans.
The ability of adoptively transferred T regs to suppress murine lupus also raises a number of questions about how exogenously expanded cells function to suppress disease that is not controlled by the endogenous T reg population. We previously demonstrated that B/W mice with active lupus have a significantly expanded T reg population that is equal to or exceeds the population found in non-autoimmune prone animals [24] . Yet it appears that this T reg expansion is insufficient to control the proliferation and function of autoreactive lymphocytes in lupus. One possible explanation for this failure is that the T reg expansion is simply insufficient to suppress the number of autoreactive lymphocytes that occur in lupus. Another possibility is that the endogenous T regs do not have proper function in vivo. Our extensive in vitro evaluation of purified B/W T regs suggest that these cells do not have a defect in their ability to suppress autologous T cell proliferation, however the true functional capacity of these cells in vivo is not known. Importantly, while the in vitro suppressive function of freshly isolated B/W T regs is equivalent to T regs isolated from non-autoimmune prone BALB/ c mice, this function can nonetheless be significantly enhanced by in vitro activation. Consistent with observations in other murine + and CTLA-4 expression. In addition, the expanded T regs demonstrate significantly enhanced in vivo survival as compared to freshly isolated cells. These data suggest a basis for the efficacy of ex-vivo expanded autologous T regs in suppressing disease in lupus prone mice. In some autoimmunity models the T effs are resistant to T reg suppression in vitro and/or in vivo [17, 36] . For this study we utilized T eff from 29-week-old mice that on average had developed antinuclear antibodies and low titers of dsDNA antibodies, but had not yet progressed to clinically active lupus. In this critical stage of disease evolution we did not observe resistance of T eff cells to CD4 + CD25 + T reg mediated in vitro suppression. It is known that T regs must undergo activation in the peripheral circulation in order to achieve a suppressor phenotype. It is thus possible that the in vitro suppression assay is insensitive to a heterogeneous T reg activation state due to the dominant suppression capacity of those T regs that have already become activated. The enhanced in vitro and likely in vivo function of T regs we observe following in vitro activation likely reflects at least in part the suppressive function of a more homogenously activated T reg population. Additional studies will be required to better characterize the factors responsible for the enhanced suppressor capacity of these expanded cells. In this study we did not attempt to compare disease suppression by supplementation of freshly isolated T regs based on several observations. The protocol to isolate highly enriched T regs results in a total recovery of fresh T regs from each donor mouse of only 400,000 to 800,000 per mouse and it would therefore require an impractical average of 8 donor mice for each treatment mouse tested. In addition, the in vivo survival of freshly isolated, CFSE labeled T regs demonstrated these cells had very poor survival relative to expanded cells decreasing the potential biologic impact of transferred freshly isolated cells.
Despite inhibition of lupus nephritis and prolonged survival, the majority of mice receiving T reg transfer progressed to active disease during long-term follow-up. This pattern of inhibiting disease onset, but not the final disease severity with a single adoptive transfer is similar to the benefit observed when a more restricted population of CD4 +
+ CD62L HI T regs was adoptively transferred. While not compared directly in a single treatment study, no significant differences in either the size or duration of the treatment response is evident between mice receiving equal numbers of expanded CD4 + CD25 + CD62L HI or CD4 + CD25 + T regs . Future studies utilizing more sensitive biomarkers of disease activity than proteinuria, antibody forma- 
2 T cell control groups (p#0.025 starting week 8, n = 22 for T reg and T eff groups, n = 21 for PBS group). doi:10.1371/journal.pone.0006031.g008 transfer. In the current study we detected transferred cells surviving and proliferating to 30 days, but the absolute number of recovered cells is small and may reflect a diminishing survival with time. From our sampling of major lymph nodes, spleen, and solid organs we estimate that ,10% of cells persist 5-7 days post transfer, ,1-3% persist 14 days post transfer, and ,1% demonstrate long term survival to our detection threshold of 30 days. Whether the delay in disease onset is due to transient nonspecific bystander suppression effect from the large number of activated T regs transferred or from the smaller number of long lived, potentially antigen specific T regs is unclear. While further studies will be required to expand the understanding of both the mechanisms of action and therapeutic potential of adoptively transferred T regs in the treatment of SLE, this study supports the potential benefits of augmenting T reg number or function as a novel therapeutic approach to the treatment of this disease.
In conclusion, our results demonstrate that exogenous expansion and adoptive transfer of the regulatory T cell subset defined by CD4 and CD25 expression produces a population of highly suppressive, long-lived T regs capable of delaying the onset of glomerulonephritis in a murine model of lupus. Co-culture and adoptive transfer of a small population of contaminating, potentially autoreactive T effs does not exacerbate autoimmune disease or limit the potential of T regs to suppress disease, in part due to the short in vivo survival time and anergic phenotype of these co-cultured cells. 
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